
### [MONDO:0000211](http://purl.obolibrary.org/obo/MONDO_0000211)
**Label:** striatal degeneration, autosomal dominant

**Subclasses:** [MONDO:0014835](http://purl.obolibrary.org/obo/MONDO_0014835) (striatal degeneration, autosomal dominant 2; ADSD2), [MONDO:0012205](http://purl.obolibrary.org/obo/MONDO_0012205) (autosomal dominant striatal neurodegeneration type 1), 

**Mapped go classes:** [GO:0043949](http://purl.obolibrary.org/obo/GO_0043949) (regulation of cAMP-mediated signaling), [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding), [GO:0090032](http://purl.obolibrary.org/obo/GO_0090032) (negative regulation of steroid hormone biosynthetic process), [GO:0008542](http://purl.obolibrary.org/obo/GO_0008542) (visual learning), [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body), [GO:0046676](http://purl.obolibrary.org/obo/GO_0046676) (negative regulation of insulin secretion), [GO:0043204](http://purl.obolibrary.org/obo/GO_0043204) (perikaryon), [GO:0005575](http://purl.obolibrary.org/obo/GO_0005575) (cellular_component), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0004118](http://purl.obolibrary.org/obo/GO_0004118) (cGMP-stimulated cyclic-nucleotide phosphodiesterase activity), [GO:0046069](http://purl.obolibrary.org/obo/GO_0046069) (cGMP catabolic process), [GO:0003824](http://purl.obolibrary.org/obo/GO_0003824) (catalytic activity), [GO:0010738](http://purl.obolibrary.org/obo/GO_0010738) (regulation of protein kinase A signaling), [GO:0008081](http://purl.obolibrary.org/obo/GO_0008081) (phosphoric diester hydrolase activity), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0008152](http://purl.obolibrary.org/obo/GO_0008152) (metabolic process), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0006198](http://purl.obolibrary.org/obo/GO_0006198) (cAMP catabolic process), [GO:0047555](http://purl.obolibrary.org/obo/GO_0047555) (3',5'-cyclic-GMP phosphodiesterase activity), [GO:0004112](http://purl.obolibrary.org/obo/GO_0004112) (cyclic-nucleotide phosphodiesterase activity), [GO:0004115](http://purl.obolibrary.org/obo/GO_0004115) (3',5'-cyclic-AMP phosphodiesterase activity), [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity), [GO:0001662](http://purl.obolibrary.org/obo/GO_0001662) (behavioral fear response), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding), [GO:0030553](http://purl.obolibrary.org/obo/GO_0030553) (cGMP binding), [GO:0050885](http://purl.obolibrary.org/obo/GO_0050885) (neuromuscular process controlling balance), [GO:0016787](http://purl.obolibrary.org/obo/GO_0016787) (hydrolase activity), [GO:0035106](http://purl.obolibrary.org/obo/GO_0035106) (operant conditioning), 

**Class expressions from DL-Learner:**

- [GO:0044297](http://purl.obolibrary.org/obo/GO_0044297) (cell body) 54.17%
- [GO:0043204](http://purl.obolibrary.org/obo/GO_0043204) (perikaryon) 54.17%
- [GO:0043025](http://purl.obolibrary.org/obo/GO_0043025) (neuronal cell body) 54.17%
- [GO:0030553](http://purl.obolibrary.org/obo/GO_0030553) (cGMP binding) 54.17%
- [GO:0030552](http://purl.obolibrary.org/obo/GO_0030552) (cAMP binding) 54.17%
- [GO:0004118](http://purl.obolibrary.org/obo/GO_0004118) (cGMP-stimulated cyclic-nucleotide phosphodiesterase activity) 54.17%
- [GO:0004115](http://purl.obolibrary.org/obo/GO_0004115) (3',5'-cyclic-AMP phosphodiesterase activity) 54.17%
- Thing 52.22%
- [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity) 49.16%
- [GO:0004112](http://purl.obolibrary.org/obo/GO_0004112) (cyclic-nucleotide phosphodiesterase activity) 49.16%
- [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 49.16%
- [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 49.16%
- [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 49.16%
- [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 49.16%
- [GO:0004114](http://purl.obolibrary.org/obo/GO_0004114) (3',5'-cyclic-nucleotide phosphodiesterase activity) and ([GO:0003674](http://purl.obolibrary.org/obo/GO_0003674) (molecular_function) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 49.16%


